Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC
SINGAPORE,Feb. 5,2025--Dentsu Japan International Brands Inc. (DJIB),the leading agency in the Japanese advertising market,has partnered with Channel Factory,a specialist in contextual targeting and m
Fourth Quarter Operating Profit Grew 36% and OP Margin1 Expanded 140 Basis Points Sequential Improvement in Same-Store Sales Index and Eighth Consecutive Quarter of Same-Store Transaction Growth
HANGZHOU,China,Feb. 6,2025-- Youdao,Inc. ("Youdao" or the "Company") (NYSE: DAO),an intelligent learning company with industry-leading technology in China,today announced that it w
SHENZHEN,China,Feb. 6,2025--MicroCloud Hologram Inc. (NASDAQ: HOLO),("HOLO" or the "Company"),a technology service provider,they have announced a significant technological breakthr
SHANGHAI,Feb. 6,2025--ShanghaiHenlius Biotech,Inc. (2696.HK) today announced it has entered into a license agreement with Dr. Reddy\'s Laboratories SA,wholly-owned subsidiary of Dr. Reddy\'s Laborator
